Basel Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	1.95	1.22	1.56
Short-Term Investments	0.09	0.1	0.1
Cash & Short-Term Investments	2.04	1.31	1.66
Cash Growth	55.27%	-20.86%	-
Accounts Receivable	1.67	1.44	2.01
Other Receivables	0.21	1.34	0.84
Receivables	12.44	13.33	13.88
Inventory	0.07	0.09	0.07
Prepaid Expenses	0.03	0.04	0.05
Other Current Assets	1.59	-	-
Total Current Assets	16.17	14.77	15.67
Property, Plant & Equipment	0.06	0.58	1.18
Long-Term Deferred Tax Assets	0.08	0.03	0
Total Assets	16.31	15.38	16.85
Accounts Payable	0.83	1.46	1.08
Accrued Expenses	1.47	0.31	0.89
Short-Term Debt	1.42	-	-
Current Portion of Long-Term Debt	2.68	3.22	3.63
Current Portion of Leases	0.03	0.57	0.57
Current Income Taxes Payable	0.44	0.48	0.39
Other Current Liabilities	0.3	0.43	0.63
Total Current Liabilities	7.16	6.47	7.19
Long-Term Debt	1.58	3.4	5.31
Long-Term Leases	-	0.03	0.64
Total Liabilities	8.75	9.89	13.14
Common Stock	24.46	0	0
Retained Earnings	7.56	5.49	3.71
Comprehensive Income & Other	-24.46	-	-
Shareholders' Equity	7.56	5.49	3.71
Total Liabilities & Equity	16.31	15.38	16.85
Total Debt	5.71	7.21	10.15
Net Cash (Debt)	-3.67	-5.9	-8.49
Net Cash Per Share	-0.23	-0.36	-0.52
Filing Date Shares Outstanding	16.25	16.25	16.25
Total Common Shares Outstanding	16.25	16.25	16.25
Working Capital	9.01	8.31	8.47
Book Value Per Share	0.47	0.34	0.23
Tangible Book Value	7.56	5.49	3.71
Tangible Book Value Per Share	0.47	0.34	0.23
Machinery	0.64	0.63	0.62

Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q